Eliza Hawkes, FRACP, MD, MBBS, Austin Health, Melbourne, Australia, comments on the development and validation of a novel prognostic system for advanced Hodgkin lymphoma (HL), A-HIPI (advanced-stage HL international prognostication index), and describes the results of a study evaluating the characteristics and outcomes of elderly patients with classical HL in Australia. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.